VitaNova Life Sciences (VNOV) FCF Margin (2017 - 2026)
VitaNova Life Sciences' (VNOV) quarterly FCF Margin came in at 2.17% in Q3 2026, down 25175.0% YoY from N/an in Q3 2025, and down 90.97% on a QoQ basis from 24.0% in Q2 2026.
Powered by 
Analysis
VitaNova Life Sciences (VNOV) FCF Margin (2017 - 2026) Analysis & Trends
VitaNova Life Sciences has disclosed FCF Margin across 7 years of filings, most recently posting 2.17% for Q3 2026.
- FCF Margin for Q3 2026 came in at 2.17%, down 25175.0% year-over-year; the trailing twelve-month figure through Jul 2026 was 17.19% (down 1895.0% YoY), and the FY2026 annual result was 26.92%, up 1968.0% from the prior year.
- FCF Margin for Q3 2026 stood at 2.17%, down from 24.0% in the prior quarter.
- Across five years, FCF Margin topped out at 253.91% in Q3 2025 and bottomed at 576.85% in Q1 2024.
- Average FCF Margin over 5 years is 55.12%, with a median of 3.0% recorded in 2024.
- The widest annual swing landed in 2023, when FCF Margin plunged 29924 bps; it then surged 71853 bps in 2025.
- Year by year, FCF Margin stood at 53.06% in 2022, then sank by 244 bps to 76.17% in 2023, then surged by 104 bps to 3.0% in 2024, then jumped by 1560 bps to 49.79% in 2025, then plunged by 96 bps to 2.17% in 2026.
- The last three FCF Margin figures came in at 2.17% (Q3 2026), 24.0% (Q2 2026), and 12.74% (Q1 2026), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Accenture | 120.96 Bn | 111.91 Bn | 6.13 Bn | 19.23% |
| 2 | UL Solutions | 12.94 Bn | 12.53 Bn | 417.00 Mn | 11.15% |
| 3 | Gartner | 11.74 Bn | 10.25 Bn | 1.19 Bn | 22.58% |
| 4 | Booz Allen Hamilton Holding | 9.28 Bn | 8.74 Bn | 1.46 Bn | 8.93% |
| 5 | Tetra Tech | 9.14 Bn | 8.91 Bn | 243.21 Mn | 17.20% |
| 6 | Genpact | 5.74 Bn | 5.22 Bn | 490.34 Mn | 4.36% |
| 7 | Grand Canyon Education | 3.97 Bn | 3.69 Bn | 204.08 Mn | 37.08% |
| 8 | Fti Consulting | 3.91 Bn | 3.74 Bn | 316.27 Mn | 14.20% |
| 9 | Korn Ferry | 3.90 Bn | 3.09 Bn | 681.29 Mn | -34.73% |
| 10 | VitaNova Life Sciences | 11.51 Mn | 9.90 Mn | 30,521.00 | 2.17% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | 24.00% |
| Jan 31, 2026 | -12.74% |
| Oct 31, 2025 | 49.79% |
| Jul 31, 2025 | 253.91% |
| Apr 30, 2025 | 24.53% |
| Jan 31, 2025 | 67.75% |
| Oct 31, 2024 | 3.00% |
| Jul 31, 2024 | -464.62% |
| Apr 30, 2024 | -35.11% |
| Jan 31, 2024 | -576.85% |
| Apr 30, 2023 | -76.17% |
| Jan 31, 2023 | -281.77% |
| Oct 31, 2022 | 53.06% |
| Jul 31, 2022 | 45.21% |
| Apr 30, 2022 | -30.74% |
| Jan 31, 2022 | 17.47% |
| Oct 31, 2021 | 43.54% |
| Jul 31, 2017 | 34.09% |